HOME >> BIOLOGY >> NEWS
Iron-binding compounds produced by marine bacteria have important implications for marine microbial ecology

(Santa Barbara, Calif.) Structures of newly-discovered siderophores (the iron-carrying molecules secreted by bacteria to facilitate iron acquisition) described in the February 18 issue of Science by researchers at the University of California, Santa Barbara and other institutions, shed light on how marine bacteria acquire iron and raise provocative questions about the evolution of iron uptake by marine bacteria.

All bacteria need iron to grow, and in the ocean there is very little iron, explained Alison Butler, professor of chemistry and biochemistry at UC, Santa Barbara and co-author of the article. "We wanted to know what molecular mechanisms control iron uptake," said Butler.

The article, "Self-Assembling Amphiphilic Siderophores from Marine Bacteria," describes the structures of the marinobactin and aquachelin siderophores which have polar peptidic head groups and hydrophobic fatty acid tails, explained Butler. "They have a hydrophobic portion and a hydrophilic portion," she said. "Like soap, they have a portion that dissolves in water and part that dissolves in grease."

The marinobactins are present as micelles (aggregations of molecules) and upon addition of iron, the micelles undergo a spontaneous phase change to form vesicles (bladder-like spheres).

When iron is added, it binds to the peptidic head, and then vesicles are formed.

"The transformation from micelle to vesicle upon iron coordination is the first example, to our knowledge, of such a metal-induced phase change in a biologically produced compound," said the authors. "The presence of this metal-induced switch raises questions about the physiological role for this transformation."

The authors were struck by the fact that different bacteria had the same 'strategy' for acquiring the iron. They state: "It is quite striking that these siderophores, whose distinctive properties hint at the possibility of a novel iron acquisition mechanism, are made by strains from two differen
'"/>

Contact: Gail Brown
gbrown@instadv.ucsb.edu
805-893-7220
University of California - Santa Barbara
16-Feb-2000


Page: 1 2 3

Related biology news :

1. Iron-binding compounds decrease body odor
2. Scientists identify compounds that mimic calorie restriction
3. New, non-radioactive screen for antimalarial compounds
4. Three molecular-targeted compounds show promise against cancers
5. Emory scientists find anti-tumor compounds in magnolia cones
6. Mouse model links alcohol intake to marijuana-like brain compounds
7. New evidence for organic compounds in deep space
8. Researchers identify compounds that might help in spinal cord repair
9. Selected estrogen compounds modify risks of vein clotting, a response to hormone replacement theraphy
10. Vitamin C produces gene-damaging compounds, test-tube study in Science reports
11. Labeling of active compounds in ginseng varies from actual content

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: